Description: Article discussing the differences in various types of reinsurance business.

Description: First dollar carriers, stop loss carriers, and reinsurers play a different role in reimbursing healthcare claims. This article explores the reinsurer's role in reimbursing COVID-19 related claims.

Description: Feature article discussing how the COVID-19 crisis has amplified the downward pressure on interest rates and amid the mounting debt levels resulting from the massive fiscal and monetary stimulus and a subdued medium-term economic outlook, monetary policies are expected to stay very accommodative for the foreseeable future.

Description: As today's medical and technological advances continue to be utilized and applied to diabetes mellitus (DM), a newer and even more complex framework for the disease is emerging, which may help us further our understanding of it. This article explores the most recent classification update and some of the newer thinking emerging about DM.

Description: Article that speaks about many of the benefits of reinsurance, including profitability optimization, risk mitigation and capital utilization improvement.

Description: This article discusses risk transfer and how difficult it is to define and describe. For actuaries, the challenge is to develop an analytical framework under which the presence of insurance risk can be identified and assessed.

Description: Canada has been proactive in establishing governance frameworks for reinsurance transactions. Initiatives from individuals, the Office of the Superintendent of Financial Institutions OSFI and the Canadian Institute of Actuaries CIA have addressed concerns about and scrutiny of reinsurance transactions from worldwide securities and insurance regulators, rating agencies and the media. It is important to note that actuaries have played a vital role in identifying and developing these initiatives and will continue to have a major influence in further development of governance standards and in providing education. From The Actuary Magazine June 2007

Description: This report examines the adoption and challenges of predictive analytics in life and annuity reinsurance, including current practices, regulatory context, and advanced AI applications.

Description: Cayman is a rapidly growing reinsurance domicile with several notable transactions executed in the past few years. We expect this trend to persist as (re)insurers will continue to explore more effective ways to manage their business. In this session, you will gain: - An overview of how the Cayman (re)insurance market has developed over recent years - An introduction to the Cayman regulatory framework - Key considerations for reinsurance structuring and pricing. Join a discussion at the close of the session on the outlook for the Cayman market. You will leave this session with an understanding of the Cayman (re)insurance market, the regulatory framework and key factors that impact reinsurance structuring and pricing.

Description: Gene therapy is a quickly evolving field and will continue to grow as a risk concern for many health plans, stop loss insurers and reinsurers. Currently, there are only two approved gene therapies in the U.S., but that number is expected to escalate starting in the fall of 2022. Revisit the experience plans have had with the first two gene therapies, discuss plan design and network considerations in light of gene therapy, and discuss the actual composition of the near-term pipeline along with a range of modeled financial impacts and considerations for payers.